Supplier Stories for the Week of February 17

Here’s what was new in the world of medical device suppliers during the week of February 17.

  • Origin announced that Henkel has joined Origin’s Open Material Network and is now developing materials for Origin’s open additive mass production platform consisting of modular hardware, extensible software, and new materials. The two companies will focus on additive mass production for the medical and other industrial sectors, including working to validate several materials with biocompatibility appropriate for medical devices.

    “We're excited about Origin's open approach and the potential for its platform to accelerate the introduction of new materials that surpass anything available on the market today,” said Philipp Loosen, head of 3D printing at Henkel, in a news release.

    Added Chris Prucha, founder and CEO of Origin: “We are eager to give customers even more material options in a diverse range of portfolio materials that can take advantage of our (P3) process such as silicones, epoxies, and polyurethanes. We believe our open network approach with Henkel and other strategic partners will fundamentally reshape manufacturing and global supply chains and we look forward to unveiling world-class and industry-defining projects in development with Henkel in the coming months.”

    Origin’s programmable photopolymerization technology (P3) enables many of Henkel chemistries with industry-leading properties as well as simple post-processing and handling, Origin reported. Examples include the medical-grade silicone sample part shown above, which has a combination of flexibility, mechanical strength, and biocompatibility, it was reported in the release. Henkel’s parent silicone resins have tested to Henkel’s protocols based upon ISO-10993 biocompatibility standards. Potential applications range from medical devices and surgery tools to pre-surgical models, hearing aids, face masks, and other devices.

    [Image courtesy of ORIGIN]

     

  • Engineered plastics manufacturer Enplas is celebrating the one-year anniversary of its rebranding of the North Carolina-based PolyLinks as "Enplas Life Tech" following its acquisition in June 2017. Over the last year, Enplas Life Tech has increased technological capabilities in manufacturing high-precision consumables.

    Enplas’s global business and Enplas Life Tech are dedicated to solving clients most difficult development problems, the company reported in an statement. From its expanded network over the United States, the global Enplas group offers customers in the life science and biotechnology industries: 

    • Easy geographical access from both east and west coasts. 

    • Availability of intricate microfluidics and auxiliary products (e.g., cartridge housings, reagent bottle sealings) including systems that require robust thermoplastic elastomer (TPE) air or liquid sealing. This applies to any life science application, from pharmaceutical manufacturing to in-vitro diagnostics (IVD) such as next generation sequencing (NGS), polymerase chain reaction (PCR), immunoassay, electrophoresis, and single-cell analysis including sample preparation. 

    • Availability of rapid prototyping and cleanroom mass production and assembly in the United States. 

    [Image courtesy of ENPLAS LIFE TECH] 

  • Phillips-Medisize, a Molex company, has launched construction of a new manufacturing facility located in the St. Croix Meadows development in Hudson, WI. The new site will be FDA registered, adhere to cleanroom practices, and feature state-of-the-art equipment to meet quality production standards, the company reported in a news release.

    “The St. Croix Meadows redevelopment is aimed at transforming the riverfront community," stated Hudson Mayor Rich O'Connor, who hosted the groundbreaking ceremony held on February 15. "By creating employment opportunities with Phillips-Medisize, I hope to encourage young people to stay in Hudson.”

    Other presenters at the groundbreaking included Klint Klaas, representative of the developer, who initiated and shaped the vision of the new St. Croix Meadows re-development project. Representing Phillips-Medisize, Dave Thoreson, vice president & general manager of North America Medical, acknowledged the developer and the City of Hudson Planning teams for their invaluable roles in advancing the project.

    “We are proud to invest in growing Phillips-Medisize’s manufacturing presence in our founding state of Wisconsin,” stated Matt Jennings, CEO and president, Phillips-Medisize, in the release. “Hudson has been home to Phillips-Medisize for the past 36 years, so we are excited to reinforce our commitment to the vibrant community with our St. Croix Meadows facility. We expect to support over 250 employment opportunities for area residents in jobs, ranging from skilled manufacturing to engineering. It also reaffirms our commitment to better serve customers as a global end-to-end provider of innovation, development and manufacturing solutions.”

    Construction is expected to be complete in the late 2019-to-mid-2020 timeframe, the company reported.

    Shown in the above photo are attendees from Phillips-Medisize, City of Hudson, St. Croix Meadows, Hudson Area Chamber of Commerce & Tourism Bureau, St. Croix Economic Development Corporation, Market & Johnson, River Valley Architects, WSB, and Leo A Daly

    [Image courtesy of PHILLIPS-MEDISIZE, A MOLEX COMPANY]

  • Mecademic showcased the Meca500, a small industrial robot arm suitable for the medical device industry, at ATX West 2019. Described as being much smaller than any other six-axis industrial robot arm, the first Meca500 was implemented into a sophisticated vision-guided microsurgery system, the company reported. And designed as a 6D positioning component, rather than a complex stand-alone system, the Meca500 can be integrated in both intricate and simple automation projects, the company claimed.

    To date about 350 units are in operation in about 24 countries around the globe. The vast majority of these robots are used in automated inspection and test applications, but many Meca500 are also used for assembly or gluing or for academic purposes, it was reported.

    Mecademic has moved into a 10,000-sq-ft facility near downtown Montreal and plans to double its team. The company has increased production capacity with equipment acquisitions such as a 5-axis automated machining center and a CMM that will be used robot calibration.

    [Image courtesy of MECADEMIC]

  • RTP Co. showcased its thermoplastic pellets, sheet, and film products at MD&M West 2019. The company shared details of its thermoplastic offerings such as:

    · Enlightened Solutions, a portfolio of thermoplastic compounds designed to reduce the weight of medical equipment and devices without sacrificing strength or performance.

    · Structural compounds for mobile medical equipment that offer strength, durability, chemical resistance, and aesthetics for hospital beds, wheelchairs, and mobile equipment like ultrasound and diagnostic machines. 

    · Color compounds for home and single-use devices that can be formulated with the ability to pass initial bio-compatibility testing, enhance branding opportunities, and be laser marked to meet FDA Unique Identification System regulations.

    [Image courtesy of RTP CO.] 

Daphne Allen

Daphne Allen is editor-in-chief of MD+DI. She previously served as executive editor of Pharmaceutical & Medical Packaging News, which serves as the pharmaceutical and medical device channel of Packaging Digest. Daphne has covered medical device manufacturing, packaging, labeling, and regulatory issues as well as pharmaceutical packaging and labeling for more than 20 years. She is also a member of the Institute of Packaging Professionals's Medical Device Packaging Technical Committee. Follow her on Twitter at @daphneallen.

 

Filed Under
500 characters remaining